Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips
04:05pm, Friday, 03'rd Jan 2025
As the calendar turns over to 2025, the leading Wall Street firms are releasing their top stock picks for the new year.
3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025
09:07am, Sunday, 29'th Dec 2024
Investors worried about a stock market sell-off may feel the urge to sell out of their positions and run for the exits. But long-term investors know that it's a mistake to overhaul your investing stra
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now
05:25am, Monday, 23'rd Dec 2024
Even with the recent bout of market volatility, 2024 has been a fantastic year for stocks. The S&P 500 index has delivered a dividend-adjusted total return of roughly 25% across this year's trading.
Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends
04:41am, Friday, 13'th Dec 2024
"A Dividend King [is] a stock with 50 or more consecutive years of dividend increases." - suredividend.com. 53 Divided Kings, screened as of December 11, 2024, represented all eleven Morningstar Secto
Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends
03:42pm, Tuesday, 10'th Dec 2024
"Dividend Aristocrats
Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months.
09:53am, Wednesday, 04'th Dec 2024
Investors often gravitate toward super safe dividend stocks to collect passive income and limit market volatility. But sometimes, even stodgy, boring companies can crush the market.
Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)
07:13am, Wednesday, 27'th Nov 2024
Kenvue's recent earnings showed improvements, but persistent headwinds, especially in the Skin, Health, & Beauty segment, suggest limited upside potential in the near term. Despite solid dividend grow
Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
06:00am, Monday, 25'th Nov 2024
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company's participation in the Morgan Stanley Global Consumer & Retail Conference in New York City. Thibaut
Tylenol maker Kenvue hails efficiency gains as activist Starboard watches on
12:41pm, Thursday, 07'th Nov 2024
Kenvue Inc (NYSE:KVUE), the maker of Listerine, Tylenol, Aveeno and Band-Aid, reported slightly lower sales than expected but earnings were just above Wall Street estimates. The company has been in a
Kenvue, Inc. (KVUE) Q3 2024 Earnings Call Transcript
11:09am, Thursday, 07'th Nov 2024
Kenvue, Inc. (NYSE:KVUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Sofya Tsinis - Head, IR Thibaut Mongon - CEO Paul Ruh - CFO Conference Call Participants Bon
Here's What Key Metrics Tell Us About Kenvue (KVUE) Q3 Earnings
10:35am, Thursday, 07'th Nov 2024
Although the revenue and EPS for Kenvue (KVUE) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stre
Kenvue (KVUE) Q3 Earnings Surpass Estimates
08:56am, Thursday, 07'th Nov 2024
Kenvue (KVUE) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.31 per share a year ago.
Kenvue misses quarterly sales estimates on sluggish skincare sales
06:51am, Thursday, 07'th Nov 2024
Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its skin health and beauty unit housing the Neutrogena and Aveeno brands, amid pressure from
Kenvue Reports Third Quarter 2024 Results
06:45am, Thursday, 07'th Nov 2024
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”), today announced financial results for the fiscal third quarter ended September 29, 2024.
Stay Ahead of the Game With Kenvue (KVUE) Q3 Earnings: Wall Street's Insights on Key Metrics
10:21am, Monday, 04'th Nov 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Kenvue (KVUE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
